期刊文献+

尿酸肾损伤的分子机制研究进展 被引量:21

Molecular mechanism of uric acid in renal injury
下载PDF
导出
摘要 高尿酸血症(HUA)长期以来被认为是痛风的致病因子,但近年来大量的流行病学和临床研究表明高尿酸血症在肾损伤的发病和发展中起了重要作用。研究表明还原型烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶、肾素—血管紧张素—醛固酮系统(RAAS)、丝裂原激活蛋白激酶(MAPK)信号、转化生长因子-β(TGF-β)、上皮间质转型等都单独的或共同的参与了肾病的发生和发展过程。目前研究争论的焦点主要集中在尿酸诱导肾损伤中的确切机制,该文主要根据现有的研究成果系统性地总结尿酸在肾损伤中的确切作用及可能的病理生理学分子机制。 Hyperuricemia has long been regarded as the major pathogenic factor in gout.A lot of epidemiological and clinical studies in recent years have accumulated that hyperuricemia may play an important role in the pathogenesis and progression of renal injury.Recent studies suggested nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase),the renin-angiotensin aldosterone system (RAAS),mitogen-activatedproteinkinases (MAPK)signals,transforming growth factor β(TGF-β),phenotypic transition of renal tubu-lar cells,etc.are activated during the course of renal injury and that these pathways individually or collectively play a role in the induc-tion and progression of renal injury.Now,controversy regarding the exact role of hyperuricemia in inducing the renal injury remains to be unfolded,the focus of this review is to systematically summarize the available evidence supporting the exact roles and mechanisms for u-ric acid in the development of renal injury and the potential pathophysiological molecular mechanisms involved.
出处 《安徽医药》 CAS 2015年第1期5-9,共5页 Anhui Medical and Pharmaceutical Journal
关键词 高尿酸血症 肾损伤 炎症 信号通路 hyperuricemia renal injury inflammation signaling pathway
  • 相关文献

参考文献35

  • 1刘伟,刘志刚,罗明琍,孙维峰,吴新荣.肾脏有机阴离子转运体在尿酸转运中的作用研究进展[J].安徽医药,2013,17(3):361-364. 被引量:8
  • 2Helm t, McFann K, Reed B, et al. Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease [ J . Nephrol Dial Transplant ,2013,28 (2) :380 - 385.
  • 3樊宗成.炎性细胞、尿酸、胆红素含量与冠脉病变的相关关系探讨[J].安徽医药,2014,18(3):541-543. 被引量:3
  • 4Takayama S,Kawamoto R,Kusunoki T,et al. Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome [ J]. Cardiovasc Diabetol, 2012,11:2.
  • 5Gerseh C,Palii SP, Kim KM, et ai. Inaetivation of nitric oxide by uric acid [ J ]. Nucleosides Nueleotides Nueleic Acids, 2008,27 (8) :967 -978.
  • 6So A,Thorens B. Uric acid transport and disease [ J]. The Journal of clinical investigation,2010,120 (6) : 1791 - 1799.
  • 7Wang Y, Bao X. Effects of uric acid on endothelial dysfunction in early chronic kidney disease and its mechanisms [ J]. Eur J Med Res ,2013,18:26.
  • 8Kang DH, Ha SK. Uric acid puzzle:Dual role as anti-oxidant and pro-oxidant[ J ]. Electrolyte Blood Press ,2014,12 ( 1 ) : 1 - 6.
  • 9SOnchez-Lozada LG, Lanaspa MA, Crist6bal-Garcla M, et al. Uric acid-induced endothelial dysfunction is associated with mitochon- drial alterations and decreased intracellular ATP concentrations [ J ]. Nephron Experimental Nephrology, 2012,121 ( 3/4 ) : e71 - e78.
  • 10Hong Q, Qi K, Feng Z, et al. Hyperurieemia induces endothelial dysfunction via mitoehondrial Na + Caz + exchanger-mediated mi- tochondrial calcium overload [ J]. Cell Calcium,2012,51 ( 5 ) : 402 -410.

二级参考文献105

  • 1王劲,罗成基,冉新泽,徐辉,粟永萍,程天民.p38对骨髓间充质干细胞成肌分化作用的研究[J].中国应用生理学杂志,2004,20(4):345-348. 被引量:3
  • 2项鹏,夏文杰,张丽蓉,陈振光,张秀明,李艳,李树浓.p38抑制剂对骨髓间质干细胞分化为脂肪细胞的影响[J].中华内分泌代谢杂志,2003,19(4):305-307. 被引量:3
  • 3陈伟,付小兵,葛世丽,姜笃银,周岗,孙同柱,韩冰,盛志勇.胎儿和出生后机体皮肤内p38MAPK及MAPKKs基因表达变化的比较性研究[J].中国修复重建外科杂志,2005,19(4):291-295. 被引量:5
  • 4余俊文,陆锦波,张小娟,杨延斌,余寿益,刘奔流.1320名老年人血尿酸与血脂、血糖和血压的分析[J].中华流行病学杂志,2005,26(6):455-457. 被引量:98
  • 5Morimoto H,Kondoh K,Nishimoto S,et al.Activation of a c-termi-nal transcriptional activation domain of ERK5 by autophos-phoryla-tion[J].J Biol Chem,2007,282(49):35449-35456.
  • 6Gírio A,Montero JC,Pandiella A,et al.Erk5 is activated and acts as asurvival factor in mitosis[J].Cell Signal,2007,19(9):1964-1972.
  • 7Cameron SJ,Abe J,Malik S,et al.Differential role of MEK5alphaand MEK5beta in BMK1/ERK5 activation[J].J Biol Chem,2004,279(2):1506-1512.
  • 8Tatake RJ,O'Neill MM,Kennedy CA,et al.Identification of phar-macological inhibitors of the MEK5/ERK5 pathway[J].BiochemBiophys Res Commun,2008,377(1):120-125.
  • 9Deng X,Yang Q,Kwiatkowski N,et al.Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a potent and se-lective inhibitor of big MAP kinase 1[J].ACS Med Chem Lett,2011,2(3):195-200.
  • 10Ye M,Luo X,Li L,et al.Grifolin,a potential antitumor naturalproduct from the mushroom Albatrellus confluens,induces cell-cy-cle arrest in G1 phase via the ERK1/2 pathway[J].Cancer Let-ters,2007,258(2):199-207.

共引文献102

同被引文献219

引证文献21

二级引证文献164

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部